AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26495916
Drug: CHO‐loading (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CHO‐loading (400 ml Nutricia pre‐op®) 2 hours prior to surgery
Trial: 19919976
Drug: SLV320 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SLV320 10 mg
Trial: 16798663
Drug: Combination treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination treatment (Simvastatin + Celiprolol)
Trial: 14747191
Drug: Breastfeeding compounds
RxNorm normalized name: BENZOIN COMPOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Breastfeeding compounds
Trial: 11031342
Drug: Macrolide antibiotic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Macrolide antibiotic treatment (n = 11)
Trial: 11031342
Drug: Placebo treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo treatment (n = 7)
Trial: 3538922
Drug: Thai Government
RxNorm normalized name: Thai galangal extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thai Government Pharmaceutical Organization (GPO) antivenom
Trial: 3538922
Drug: Twyford Pharmaceutical
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Twyford Pharmaceutical antivenom
Trial: 27231160
Drug: Stents-combination (Group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Stents-combination (Group I)
Trial: 18662172
Drug: Daptomycin at
RxNorm normalized name: Daptomycin
DrugBank: Daptomycin (DB00080)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Daptomycin at 10 mg/kg every 24 h for 4 days
Trial: 18662172
Drug: Standard of
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard of care therapy with vancomycin or semi-synthetic penicillin
Trial: 2209033
Drug: No weekly
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No weekly change (NWC)
Trial: 31132302
Drug: Mindfulness module
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Mindfulness module of dialectical behavioural therapy (DBT‐M)
Trial: 11429362
Drug: Multiple injection
RxNorm normalized name: sodium acetate
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Multiple injection technique
Trial: 9894701
Drug: Naloxone (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (0.02 mg/kg)
Trial: 7994448
Drug: Aspirin 100
RxNorm normalized name: aspirin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin 100 mg oid
Trial: 2680083
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg of phenylpropanolamine HCl (PPA)
Trial: 5551272
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron 30 mg once daily
Trial: 5551272
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron 60 mg once daily
Trial: 5551272
Drug: Oral iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral iron 120 mg once daily
Trial: 5551272
Drug: Parenteral iron
RxNorm normalized name: Iron, parenteral preparations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parenteral iron 1 g followed by oral iron 60 mg
Trial: 29677345
Drug: 60-mg caffeine
RxNorm normalized name: caffeine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 60-mg caffeine group
Trial: 29677345
Drug: 120-mg caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 120-mg caffeine group
Trial: 29677345
Drug: 180-mg caffeine
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 180-mg caffeine group
Trial: 29677345
Drug: 0-mg group
RxNorm normalized name: meningococcal group B vaccine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0-mg group (control)
Trial: 28643901
Drug: Ferric carboxymaltose
RxNorm normalized name: Ferric Carboxymaltose
DrugBank: Ferric carboxymaltose (DB08917)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Ferric carboxymaltose (1000 mg iron)
Trial: 26683949
Drug: DAPT +
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT + atorvastatin 20 mg daily + lansoprazole 30 mg daily (Group A)
Trial: 26683949
Drug: DAPT +
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT + atorvastatin 20 mg daily (Group B)
Trial: 26683949
Drug: DAPT +
RxNorm normalized name: DAPT
DrugBank: Diaminopropanol tetraacetic acid (DB12362)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DAPT + lansoprazole 30 mg daily (Group C)
Trial: 20843556
Drug: lithium (1‐1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lithium (1‐1.2 mEq/L) + tamoxifen 80 mg/day
Trial: 20843556
Drug: lithium (1‐1.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: lithium (1‐1.2 mEq/L) + placebo
Trial: 18939399
Drug: Intravenous Tramadol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous Tramadol (100 mg) and IV hyoscine N butylbromide (20 mg)
Trial: 18939399
Drug: IV hyoscine
RxNorm normalized name: HYOSCINE HYDROBROMIDE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV hyoscine N butylbromide (20 mg) only
Trial: 8885906
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens (0.625 mg) and medroxyprogesterone (10 mg) cyclically for 3 months
Trial: 1520045
Drug: Gemfibrozil 600
RxNorm normalized name: gemfibrozil 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemfibrozil 600 mg twice daily for 6 weeks
Trial: 1520045
Drug: Lovastatin 20
RxNorm normalized name: lovastatin 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lovastatin 20 mg twice daily for 6 weeks
Trial: 6500763
Drug: Isofezolac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isofezolac (50 mg) alone
Trial: 6500763
Drug: Isofezolac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isofezolac (50 mg) with aspirin (1 g)
Trial: 6500763
Drug: Isofezolac (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isofezolac (50 mg) with phosphalugel (11 g aluminum phosphate)
Trial: 30895459
Drug: Suspension with
RxNorm normalized name: SUSPENSION WITH PREFILLED APPLICATOR(ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Suspension with prior climbing
Trial: 30895459
Drug: Suspension without
RxNorm normalized name: threonine
DrugBank: Threonine (DB00156)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Suspension without prior climbing
Trial: 30895459
Drug: Post-suspension recovery
RxNorm normalized name: post oak pollen extract
DrugBank: Quercus stellata pollen (DB10888)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Post-suspension recovery
Trial: 26768572
Drug: Ebola vaccine
RxNorm normalized name: ebola vaccines
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ebola vaccine intervention
Trial: 22569288
Drug: Daily atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily atorvastatin (QD)
Trial: 22569288
Drug: Alternate-day atorvastatin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alternate-day atorvastatin (QOD)
Trial: 12910715
Drug: KC-404 sustained
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: KC-404 sustained release tablets (20 mg)
Trial: 12910715
Drug: KC-404 capsules
RxNorm normalized name: hydrocortisone
DrugBank: Hydrocortisone succinate (DB14545)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: KC-404 capsules (20 mg)
Trial: 28816883
Drug: 0.01 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg/kg IV atropine
Trial: 19948946
Drug: Grapefruit juice
RxNorm normalized name: grapefruit juice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Grapefruit juice with 400 mg nilotinib
Trial: 19948946
Drug: Water with
RxNorm normalized name: sterile water with electrolytes injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Water with 400 mg nilotinib
Trial: 15819283
Drug: Etoricoxib, 30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etoricoxib, 30 mg once daily
Trial: 15819283
Drug: Ibuprofen, 800
RxNorm normalized name: Ibuprofen, 800 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen, 800 mg 3 times daily
Trial: 6419596
Drug: Auranofin (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Auranofin (6 mg per day)
Trial: 6419596
Drug: D-penicillamine (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-penicillamine (500 mg per day)
Trial: 30709557
Drug: Combined aprepitant
RxNorm normalized name: Aprepitant
DrugBank: Aprepitant (DB00673)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined aprepitant therapy (aprepitant plus dexamethasone and tropisetron)
Trial: 30709557
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (dexamethasone and tropisetron)
Trial: 26921267
Drug: Mindfulness-Based Stress
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mindfulness-Based Stress Reduction (MBSR) as an add-on to treatment as usual (TAU)
Trial: 26921267
Drug: Psychoeducational programme
RxNorm normalized name: Immunoglobulin G4, anti-programmed cell death protein 1 (PDCD1) (humanized clone ABT1 gamma4-chain), disulfide with humanized clone ABT1 kappa-chain, dimer
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Psychoeducational programme (FibroQoL) as an add-on to treatment as usual (TAU)
Trial: 22127729
Drug: Alendronate treatment
RxNorm normalized name: alendronate
DrugBank: Alendronic acid (DB00630)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Alendronate treatment group
Trial: 17370037
Drug: Docetaxel 100
RxNorm normalized name: Docetaxel
DrugBank: Docetaxel (DB01248)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Docetaxel 100 mg/m2 over 1 h on day 1 followed by ifosfamide 5 g/m2 divided over days 1 and 2 (2.5 g/m2/day over 1 h), recycled every 21 days with prophylactic G-CSF administration from day 3 until a neutrophil count >10,000/microl.
Trial: 8586834
Drug: Cyclosporin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (10 mg/kg twice a day orally) with exogenous angiotensin II (1 ng/kg per min intravenously)
Trial: 8586834
Drug: Cyclosporin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (10 mg/kg twice a day orally) with frusemide (40 mg/day orally for 2 days)
Trial: 8586834
Drug: Cyclosporin (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporin (10 mg/kg twice a day orally)
Trial: 2710909
Drug: Cognitive therapy
RxNorm normalized name: cognitive therapy software
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive therapy (N = 30)
Trial: 2710909
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no treatment, N = 20)
Trial: 31542980
Drug: Nicotine inhaler
RxNorm normalized name: nicotine Inhalation Solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nicotine inhaler (4 mg deliverable)
Trial: 31542980
Drug: Perceived nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Perceived nicotine administration
Trial: 31542980
Drug: Unexpected nicotine
RxNorm normalized name: Nicotine
DrugBank: Nicotine (DB00184)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Unexpected nicotine administration
Trial: 25291152
Drug: Racemic metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Racemic metoprolol tartrate 100 mg oral dose
Trial: 19182682
Drug: Antidyspeptic drugs
RxNorm normalized name: Listerine Antiseptic
DrugBank: Menthol (DB14123)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidyspeptic drugs usage
Trial: 2036693
Drug: 0.01 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.01 mg.kg‐1 atropine iv one minute before fentanyl (Group 3)
Trial: 2036693
Drug: 0.2 mg.kg‐1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg.kg‐1 morphine im one hour before fentanyl (Group 4)
Trial: 2036693
Drug: 7.5 mg
RxNorm normalized name: biotin 7.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 7.5 mg midazolam po one hour before fentanyl (Group 5)
Trial: 7272896
Drug: Protected environment-prophylactic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protected environment-prophylactic antibiotic (PEPA)
Trial: 9861551
Drug: Immediate-release methylphenidate
RxNorm normalized name: methylphenidate Extended Release Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release methylphenidate (IR; 20-40 mg)
Trial: 9861551
Drug: Sustained-release methylphenidate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release methylphenidate (SR; 20-40 mg)
Trial: 30907346
Drug: Integrated sandplay
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Integrated sandplay therapy in addition to routine training
Trial: 19183412
Drug: Combined treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined treatment (bromfenac and betamethasone)
Trial: 9855322
Drug: Aminophylline 350
RxNorm normalized name: aminophylline 350 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aminophylline 350 mg
Trial: 7861791
Drug: Ethanol (1.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ethanol (1.0 g/kg, divided into two equal doses given 75 minutes apart)
Trial: 21972626
Drug: Electroacupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture and acupoint injection with Neostigmine (in addition to conventional western medicine)
Trial: 21972626
Drug: Conventional western
RxNorm normalized name: western larch pollen extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional western medicine (control group)
Trial: 21972626
Drug: Electroacupuncture and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electroacupuncture and acupoint injection with Neostigmine
Trial: 12135284
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) at cumulative doses of 3.75 mg/kg for 5 days
Trial: 12135284
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) at cumulative doses of 7.5 mg/kg for 5 days
Trial: 12135284
Drug: Liposomal amphotericin
RxNorm normalized name: Liposomal amphotericin B
DrugBank: Amphotericin B (DB00681)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Liposomal amphotericin B (AmBisome) at cumulative doses of 15.0 mg/kg for 5 days
Trial: 31255890
Drug: Standard multimodal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard multimodal analgesia (routine paracetamol and tramadol PCA in addition to diclophenac sodium as rescue analgesia)
Trial: 26401826
Drug: 2‐DeNT Oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2‐DeNT Oral Topical Powder
Trial: 25329470
Drug: Participatory women's
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Participatory women's health groups intervention with monthly meetings and a participatory learning and action cycle.
Trial: 9234028
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group (60 g breakfast cereal daily with semi-skimmed milk)
Trial: 8383096
Drug: Ketoconazole 400
RxNorm normalized name: ketoconazole 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketoconazole 400 mg daily for 7 days
Trial: 8383096
Drug: Itraconazole 200
RxNorm normalized name: itraconazole 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole 200 mg orally, or clotrimazole 200 mg intravaginally, twice weekly for six months
Trial: 3770039
Drug: Pneumococcal vaccine
RxNorm normalized name: PNEUMOCOCCAL VACCINE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pneumococcal vaccine (Moniarix)
Trial: 21143869
Drug: Procalcitonin-guided treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Procalcitonin-guided treatment
Trial: 18607265
Drug: 5 g
RxNorm normalized name: 15 g/31 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 g of rice cereal added to 100 mL standard formula (group B)
Trial: 18607265
Drug: Formula manufactured
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Formula manufactured with bean gum as a thickening agent (group C)
Trial: 10918827
Drug: Treatment in
RxNorm normalized name: Other agents for local oral treatment in ATC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment in a stroke unit
Trial: 8878223
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (three times daily for 10 days)
Trial: 1457110
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow at N2O 1 L/min and O2 0.6 L/min (Group 1)
Trial: 1457110
Drug: Fresh gas
RxNorm normalized name: Peroxi-Fresh
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fresh gas flow at N2O 0.5 L/min and O2 0.5 L/min (Group 2)
Trial: 3888246
Drug: Oral methoxsalen
RxNorm normalized name: Methoxsalen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methoxsalen (13 cases)
Trial: 3888246
Drug: 1% methoxsalen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1% methoxsalen cream (33 cases)
Trial: 31861038
Drug: Intravenous cannula
RxNorm normalized name: CANNULA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cannula
Trial: 29399799
Drug: Intravenous plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous plus intra-articular tranexamic acid (20 mg/kg intravenous and 3.0 g intra-articular)
Trial: 29399799
Drug: Intra-articular tranexamic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intra-articular tranexamic acid alone (3.0 g intra-articular and normal saline intravenous)
Trial: 29399799
Drug: Intravenous plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous plus intra-articular tranexamic acid
Trial: 17074952
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual plus contingency management
Trial: 15284214
Drug: Estradiol 1
RxNorm normalized name: estradiol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol 1 mg + Dydrogesterone 5 mg (group D)
Trial: 15284214
Drug: Estradiol 1
RxNorm normalized name: estradiol 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estradiol 1 mg + Norethisterone 0.5 mg (group N)
Trial: 11716200
Drug: Lactose (doses
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose (doses ranging from 6.25 mg to 100 mg)
Trial: 11716200
Drug: Lactose (higher
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lactose (higher than normal clinical doses)
Trial: 22943662
Drug: 200 mg/day
RxNorm normalized name: alpelisib 200 mg/day (200 mg x 1) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200 mg/day ketoprofen
Trial: 22943662
Drug: 300 mg/day
RxNorm normalized name: alpelisib 300 mg/day (150 mg x 2) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 mg/day ketoprofen
Trial: 24301242
Drug: Desoximetasone spray
RxNorm normalized name: desoximetasone Topical Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Desoximetasone spray 0.25% twice daily
Trial: 24301242
Drug: Vehicle spray
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vehicle spray twice daily
Trial: 12166347
Drug: Ibuprofen up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen up to 1200 mg daily for 1-7 days
Trial: 12166347
Drug: Paracetamol up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol up to 3000 mg daily for 1-7 days
Trial: 12166347
Drug: Aspirin up
RxNorm normalized name: Q-Up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin up to 3000 mg daily for 1-7 days
Trial: 7988577
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.083 mg ml-1 of diamorphine in 0.167% bupivacaine
Trial: 7988577
Drug: Epidural infusion
RxNorm normalized name: epidural administration set EPIDURAL INFUSION SETS-PARAPHERNALIA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Epidural infusion of 0.083 mg ml-1 of diamorphine in 0.9% NaCl solution (control)
Trial: 2925353
Drug: Mazindol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mazindol (2 mg, oral administration)
Trial: 11695211
Drug: New dentifrice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New dentifrice formulation variant (Colgate Total Plus Whitening Toothpaste)
Trial: 29198062
Drug: Heparin in
RxNorm normalized name: heparin Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin in saline (H)
Trial: 29198062
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and albumin in saline (HA)
Trial: 29198062
Drug: Heparin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin and albumin in combination with a citrate-containing dialysate (HAC)
Trial: 29198062
Drug: Saline and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline and using heparin-coated filters (Evodial®)
Trial: 25080293
Drug: IGF1 titration
RxNorm normalized name: apomorphine
DrugBank: Apomorphine (DB00714)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: IGF1 titration
Trial: 25080293
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose (67 μg/kg per day)
Trial: 25080293
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose (35 μg/kg per day)